COVID Vaccine Invented Before COVID, What’s Going On? (NIAID, Moderna Had COVID Vaccine Candidate in December 2019) (Mercola, MD)

RSS Feed

COVID Vaccine Invented Before COVID, What’s Going On? (NIAID, Moderna Had COVID Vaccine Candidate in December 2019) (Mercola, MD)

July 12th, 2021

Awake Goy

Story at-a-glance

Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill on December 12, 2019 — raising significant red flags
The providers agreed to transfer “mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna” to the university’s investigator and was signed by Ralph Baric
Baric pioneered techniques for genetically manipulating coronaviruses, which became a major focus for research at the Wuhan Institute of Virology (WIV)
Baric worked closely with WIV’s Shi Zhengli, Ph.D., on research using genetic engineering to create a “new bat SARS-like virus … that can jump directly from its bat hosts to humans”
Serious questions need to be answered, including: Were Moderna, NIAID and Baric aware that COVID-19 was circulating in mid-December 2019, or did they have knowledge far before that such a vaccine would soon be in demand?

So much has happened over the past year that it may be hard to remember what life was like pre-COVID. But let’s flash back to December 2019, when the idea of social distancing, compulsory masking and lockdowns would have been met with disbelief and outrage by most Americans.

At that time, most were blissfully unaware of the pandemic that would change the world in the next few months. It wasn’t until December 31, 2019, that the COVID-19 outbreak was first reported from Wuhan, China,¹ and at this point it was only referred to as cases of viral pneumonia, not a novel coronavirus.² I say “most” because it seems some people may have been aware of something lurking much earlier than it appeared.

In confidential documents³ revealed by the U.K.’s Daily Expose, Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill December 12, 2019 — raising significant red flags. As The Daily Expose reported:⁴

“What did Moderna [and NIAID] know that we didn’t? In 2019 there was not any singular coronavirus posing a threat to humanity which would warrant a vaccine, and evidence suggests there hasn’t been a singular coronavirus posing a threat to humanity throughout 2020 and 2021 either.”

COVID-19 Vaccine Candidate Was Released Prior to Pandemic

The confidential disclosure agreement relays a material transfer agreement between the providers — Moderna, NIAID and the National Institutes of Health (NIH) — and the University of North Carolina at Chapel Hill. The providers agreed to transfer “mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna” to the university’s investigator.⁵

“The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019,” Daily Expose noted.

At this point, some backstory information is more than relevant. We know with great certainty that researchers at China’s Wuhan Institute of Virology (WIV) had access to and were doing gain-of-function research on coronaviruses, and manipulating them to become more infectious and to more easily infect humans. We also know that they collaborated with scientists in the U.S. and received funding from the National Institutes of Health for such research.